-
Novel drug bezisterim plans for further study in Long COVID. Here’s how the phase 2 trial came together.
Novel anti-inflammatory drug shows early promise in treating Long COVID cognitive symptoms, fatigue, PEM. The study looked at multiple endpoints and consulted with people living with the disease. Read more…
Recent articles
Get the latest Long COVID news and commentary
Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
Check out our weekly podcast, Still Here
Spotify
Apple Podcasts
PocketCasts
iHeartRadio
RSS
Policy & Advocacy
-
Congress’s 2027 budget could include new funding for Long COVID and ME
-
How to protect your community from ICE when you have Long COVID
-
Wastewater testing is vital for public health. It needs sustained funding to continue beyond fall 2026.
-
I worked in homeless services for years. It didn’t help me find accessible housing when I got Long COVID.
-
The U.K.’s plan for ME has failed us. Members of parliament must step up.
-
How is Minnesota addressing Long COVID?
Science
Covid-19
Health
-
VIPER aims to fast track Long COVID biomarkers. Here’s how it works.
-
How do you spot Long COVID misinformation?
-
Dysautonomia conference centers biomarkers and post-exertional malaise
-
Experimental peptides are being advertised for Long COVID. But the evidence is trailing behind.
-
Stop telling women their Long COVID is menopause
-
Wastewater testing is vital for public health. It needs sustained funding to continue beyond fall 2026.
-
Stop telling women their Long COVID is menopause
-
How to protect your community from ICE when you have Long COVID
-
Editor’s letter: Fight Long COVID denial by becoming a Supporter of The Sick Times
-
I worked in homeless services for years. It didn’t help me find accessible housing when I got Long COVID.